Diagnostics News and Research

RSS

Cepheid announces new TB test for use in developing countries

The Sunnyvale, Calif.-based company Cepheid on Tuesday announced it has developed a rapid diagnostic test for tuberculosis that it will sell at a reduced cost in developing countries, the San Francisco Chronicle reports. The test was developed in partnership with the Foundation for Innovative New Diagnostics, the University of Medicine and Dentistry of New Jersey, and the National Institute of Allergy and Infectious Diseases.

30 Mar 2009

Salk Institute forms strategic alliance agreement with sanofi-aventis

The Salk Institute has announced that it has signed a strategic alliance agreement with sanofi-aventis, establishing a joint program that supports cutting-edge research and promotes an exchange of discoveries focused on scientific advances and therapeutic applications.

29 Mar 2009

More cancer patients cured according to new data on cancer survival in Europe

New data and analyses from a long-running study of cancer survival in Europe have shown that the number of people actually cured of cancer - rather than just surviving for at least five years after diagnosis - is rising steadily.

23 Mar 2009

New tumor markers determine therapy intensity

Characteristic changes in the DNA of medulloblastoma, the most frequent malignant brain tumor in childhood, indicate precisely how aggressively the tumor will continue to spread and what the chances of disease relapse are.

17 Mar 2009

Sensitive new test for protein detection

Scientists at the Naval Research Laboratory (NRL) recently reported the detection of toxins with unprecedented speed, sensitivity, and simplicity.

16 Mar 2009

ATCC develops and isolates novel avian flu monoclonal antibodies

ATCC (American Type Culture Collection) researchers have developed a panel of novel monoclonal antibodies (mAbs) against avian influenza viruses. These antibodies could lead to a rapid diagnostic test for the infection, ATCC announced today. The organization has filed a patent covering the development of these novel antibodies.

16 Mar 2009

A vaccine for multiple sclerosis

Apitope Technology Ltd is a biopharmaceutical company that specialises in developing treatments for allergy and autoimmune diseases.

11 Mar 2009

Azaya Therapeutics selected for Nanotechnology Characterization Lab by National Cancer Institute

Azaya Therapeutics, Inc. has announced that it has been selected by the National Cancer Institute (NCI) for a research collaboration to study Azaya's lead cancer therapy, ATI - 1123.

10 Mar 2009

Patented inventions double at University at Buffalo

An antibody with the potential to stop breast cancer in its path. A nanoparticle that can address a side effect of the treatment that hemophiliacs cannot live without. A "quantum dot" with the potential to treat cancer or harvest the power of the sun. An air purifier that kills the world's nastiest toxins.

5 Mar 2009

Influenza A's resistance to drug Tamiflu increasing

Influenza A viruses (H1N1 subtype) that are resistant to the drug oseltamivir circulated widely in the U.S. during the 2007-2008 influenza season, with an even higher prevalence of drug resistance during the current 2008-2009 influenza season, according to a study to be published in the March 11 issue of JAMA, the Journal of the American Medical Association.

2 Mar 2009

New technique to determine tumor methylation status

Current research suggests that a new technique to determine tumor methylation status can be used in archived tissue samples.

23 Feb 2009

Gold nanoparticles improve gene regulation

Investigators at Northwestern University have found that packing small interfering RNA (siRNA) molecules onto the surface of a gold nanoparticle can protect siRNAs from degradation and increase their ability to regulate genes involved in cancer. As a result of this discovery, cancer researchers have at their disposal a relatively straightforward method of delivering these potent gene-regulating agents into targeted cells.

23 Feb 2009

B-cell clones as early markers for chronic lymphocytic leukemia

Testing of blood specimens may detect abnormal white blood cells in patients years before the chronic form of lymphocytic leukemia (CLL) develops, according to research published in the current issue of the New England Journal of Medicine.

22 Feb 2009

Faster detection of viruses with nanodevices

A more specific and faster detection of viruses has been identified in new research by Trinity College Dublin's Professor of Physics, Martin Hegner at Trinity College's Centre of Research on Adaptive Nanostructures and Nanodevices (CRANN) and an international team of researchers.

17 Feb 2009

Remote Intelligent Drug Delivery System (RIDDS) may soon be a reality

Electronic implants that dispense medicines automatically or via a wireless medical network are on the horizon. Australian and US researchers warn of the security risks in a forthcoming issue of the International Journal of Biomedical Engineering and Technology .

8 Feb 2009

HIPAA privacy rule fails to adequately protect patient privacy and hampers health research

The Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule does not adequately protect the privacy of people's personal health information and hinders important health research discoveries, concludes a new report from the Institute of Medicine.

5 Feb 2009

NRL partners with industry to develop compact biosensor for wide-ranging applications

Scientists at the Naval Research Laboratory (NRL) are partnering with industry to develop a sensor system for biomolecules that could make a significant contribution to a variety of fields such as healthcare, veterinary diagnostics, food safety, environmental testing, and national security.

3 Feb 2009

Quinolone-resistant gonorrhea increases in Ontario

The prevalence of quinolone-resistant gonorrhea has increased rapidly in Ontario - Canada's most populous province - from a rate of 2% in 2001 to 28% in 2006, found a study published in CMAJ.

2 Feb 2009

BioGenes as new designated partner in EU funded dementia project

BioGenes GmbH, a specialist in sophisticated antibody development, has been chosen as a new partner of cNEUPRO. cNEUPRO is a EU funded research project to analyse neurodegenerative diseases and discover novel biomarkers, and so improve early and differential diagnosis of Alzheimer's dementia.

2 Feb 2009

Epigenetics may account for some inherited traits and diseases

Embargoed Until January 18, 2009 at 18:00 Greenwich Mean Time / 13:00 Eastern Standard Time (TORONTO): Scientists at the Centre for Addiction and Mental Health (CAMH) have detected evidence that DNA may not be the only carrier of heritable information; a secondary molecular mechanism called epigenetics may also account for some inherited traits and diseases.

19 Jan 2009